• About
  • Privacy Policy
  • Terms Of Use
  • Contact
Sunday, April 2, 2023
Pharma Info Nepal
  • Home
  • Loksewa
  • License
  • Questions
  • Vacancy
  • Downloads
  • Notice
  • Pharmacy Books
  • Pharmacy Notes
No Result
View All Result
  • Home
  • Loksewa
  • License
  • Questions
  • Vacancy
  • Downloads
  • Notice
  • Pharmacy Books
  • Pharmacy Notes
No Result
View All Result
Pharma Info Nepal
No Result
View All Result
Home Notice

WHO Alert on 4 Indian Cough Syrups as 66 Gambian Kids Die

WHO Alert on 4 Indian Cough Syrups as 66 Gambian Kids Die

Nabin Bista by Nabin Bista
October 13, 2022
in Notice, Updates
0
WHO Alert on 4 Indian Cough Syrups as 66 Gambian Kids Die
158
VIEWS
Share on FacebookShare on Twitter

WHO Alert on 4 Indian Cough Syrups as 66 Gambian Kids Die

Substandard (contaminated) paediatric medicines identified in WHO region of Africa

This WHO Medical Product Alert refers to four substandard products, identified in The Gambia and reported to WHO in September 2022. Substandard medical products are products that fail to meet either their quality standards or specifications and are, therefore “out of specification”

The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup. The stated manufacturer of these products is Maiden Pharmaceuticals Limited (Haryana, India). To date, the stated manufacturer has not provided guarantees to WHO on the safety and quality of these products.

Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants. To date, these four products have been identified in The Gambia, but may have been distributed, through informal markets, to other countries or regions

Risks

Diethylene glycol and ethylene glycol are toxic to humans when consumed and can prove fatal

  • Toxic effects can include abdominal pain, vomiting, diarrhoea, inability to pass urine, headache, altered mental state, and acute kidney injury which may lead to death.
  • All batches of these products should be considered unsafe until they can be analyzed by the relevant National Regulatory Authorities.
  • The substandard products referenced in this alert are unsafe and their use, especially in children, may result in serious injury or death.

Advice to regulatory authorities and the public

It is important to detect and remove these substandard products from circulation to prevent harm to patients.

WHO requests increased surveillance and diligence within the supply chains of countries and regions likely to be affected by these products. Increased surveillance of the informal/unregulated market is also advised.

All medical products must be approved and obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked. Seek advice from a healthcare professional when in doubt.

If you have these substandard products, please DO NOT use them. If you, or someone you know, have used these products or suffered any adverse reaction/event after use, you are advised to seek immediate medical advice from a qualified healthcare professional and report the incident to the National Regulatory Authority or National Pharmacovigilance Centre.

National regulatory/health authorities are advised to immediately notify WHO if these substandard products are discovered in their respective country. If you have any information concerning the manufacture or supply of these products, please contact WHO via  rapidalert@who.int

Please click here for details and photos of the substandard products referenced in Alert N°6/2022.

WHO definitions: https://www.who.int/teams/regulation-prequalification/incidents-and-SF/background/definitions


Source: WHO



  • WHO Recommends Long Acting Cabotegravir for HIV Prevention

 

Tags: Drug RecallWHO
Previous Post

Vacancy Announcement for Pharmacist Health Insurance Board Nepal 

Next Post

Vacancy Announcement for Technical Advisor Pharmacist – SPARS

Nabin Bista

Nabin Bista

Hello, Thank You for visiting my blog I am Nabin Bista, Dedicated and self motivated young Pharmacist from Nepal. Blogging is my passion. I am studying B Pharmacy at Institute of Medicine - IOM. If you want me to write about any posts that you found confusing/difficult, please mention in the comments below.

Related Posts

Diploma Pharmacy New Curriculum 2nd and 3rd Year CTEVT

Diploma Pharmacy New Curriculum 2nd and 3rd Year CTEVT

March 27, 2023
B Pharmacy Seats Distribution in Nepal for Academic Year 2079/2080 

B Pharmacy Seats Distribution in Nepal for Academic Year 2079/2080 

March 21, 2023
Association of Pharmaceutical Producers of Nepal (APPON)

Association of Pharmaceutical Producers of Nepal (APPON)

March 5, 2023
Pharma Info Nepal | Nepal's No. 1 Pharmacy Blog

Drug and Medicine Related Act, Rules, Regulations, Policies, Guidelines & Directives in Nepal

February 1, 2023
Load More
Next Post
Vacancy Announcement Technical Advisor Pharmacist - SPARS

Vacancy Announcement for Technical Advisor Pharmacist - SPARS

Discussion about this post

Recommended

Emergency use of Moderna COVID-19 mRNA vaccine Allowed in Nepal 

Emergency use of Moderna COVID-19 mRNA vaccine Allowed in Nepal 

2 years ago
Clinical Trials of Drugs 

Clinical Trials of Drugs 

1 year ago

Don't Miss

Pharmacy Officer Loksewa Question Paper Solution 2079 

Pharmacy Officer Loksewa Question Paper Solution 2079 

April 1, 2023
Diploma Pharmacy New Curriculum 2nd and 3rd Year CTEVT

Diploma Pharmacy New Curriculum 2nd and 3rd Year CTEVT

March 27, 2023
Vacancy Announcement for Consultant Quality Management Systems Internal Auditor Training and Assist on Internal Quality Audit at DDA

Vacancy Announcement for QMS Internal Auditor Consultant MSH

March 22, 2023
Vacancy Announcement Procurement and Supply Management (PSM) Specialist

Vacancy Announcement Procurement and Supply Management (PSM) Specialist

March 21, 2023

About Pharma Info Nepal

Pharma Info Nepal (Nabin’s Blog) was initiated in 2019 with the aim of providing relevant and accurate information for pharmacy, nursing and other health professionals. Since then it is conveying health related educational and informational updates of Nepal. It serves as a source for learning materials on diverse topics relating to medicine intended basically for pharmacy and nursing students. It covers job opportunities, question collections for pharmacy license, nursing license as well as various competitive exams.

Our readers rely on us for the well referenced and latest updates collected from the reliable sites.

Follow us

  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Instagram

Information Reader

Contents (text, image, graphics, documents and other materials) published on this portal are collected from other relevant sources with the sole purpose of sharing information. Contents and features are subject to change and all rights reserved to Pharma info Nepal. The information presented on this web portal and its official social media handles have no affiliation to any organization that author is involved with either professionally or personally.

If you have found anything displayed incorrectly or have further suggestions on improving our effort, please do not hesitate to reach out at pharmainfonepal1@gmail.com !
We hope you find Pharma info Nepal a helpful site. Thanks !!!

Categories

  • B Pharmacy
  • Colleges
  • D Pharmacy
  • Downloads
  • License
  • Loksewa
  • M Pharmacy
  • Medicinal Chemistry
  • Notice
  • Nursing
  • Pharmacognosy
  • Pharmacology
  • Pharmacy Notes
  • Questions
  • Scholarship
  • Study Materials
  • Syllabus
  • Updates
  • Vacancy

DOWNLOADS

Pharmacy Book 

Pharmacy Act and Guidelines

About Pharma Info Nepal

About Admin

  • About
  • Privacy Policy
  • Terms Of Use
  • Contact

© 2021 Nabin's Blog

No Result
View All Result
  • Home
  • Loksewa
  • License
  • Questions
  • Vacancy
  • Downloads
  • Notice
  • Pharmacy Books
  • Pharmacy Notes

© 2021 Nabin's Blog

error: